4//SEC Filing
White David 4
Accession 0001209191-20-013257
CIK 0001175505other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 8:13 PM ET
Size
9.3 KB
Accession
0001209191-20-013257
Insider Transaction Report
Form 4
White David
See Remarks
Transactions
- Award
Common Stock
2020-01-20+20,000→ 35,000 total - Award
Common Stock
2020-02-24+10,000→ 45,000 total - Award
Employee Stock Option (right to buy)
2020-02-24+25,000→ 25,000 totalExercise: $5.25Exp: 2030-02-23→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Represents shares of restricted stock, which will vest in its entirety on September 30, 2020, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through such date.
- [F2]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 24, 2021, 2022 and 2023, provided the reporting person provides services to the Company through each such date.
- [F3]The shares underlying this option vest at a rate of one forty-eighth (1/48) per month following February 24, 2020, provided the reporting person provides services to the Company through each such date.
Documents
Issuer
FIVE PRIME THERAPEUTICS, INC.
CIK 0001175505
Entity typeother
Related Parties
1- filerCIK 0001329049
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 8:13 PM ET
- Size
- 9.3 KB